Sage CEO hopes for a Prozac moment with experimental depression drug
December 08, 2017 at 13:33 PM EST
Sage Therapeutics CEO Jeff Jonas hopes a drug in development for major depressive disorder will be as big as Prozac.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|